North America Inhalation Anesthesia Market Size, Share & Industry Trends Analysis Report By Drug (Sevoflurane, Desflurane, Isoflurane, and Others), By Application (Maintenance and Induction), By Country and Growth Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Inhalation Anesthesia Market, by Drug
1.4.2 North America Inhalation Anesthesia Market, by Application
1.4.3 North America Inhalation Anesthesia Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. North America Inhalation Anesthesia Market by Drug
3.1 North America Sevoflurane Market by Country
3.2 North America Desflurane Market by Country
3.3 North America Isoflurane Market by Country
3.4 North America Others Market by Country

Chapter 4. North America Inhalation Anesthesia Market by Application
4.1 North America Maintenance Market by Country
4.2 North America Induction Market by Country

Chapter 5. North America Inhalation Anesthesia Market by Country
5.1 US Inhalation Anesthesia Market
5.1.1 US Inhalation Anesthesia Market by Drug
5.1.2 US Inhalation Anesthesia Market by Application
5.2 Canada Inhalation Anesthesia Market
5.2.1 Canada Inhalation Anesthesia Market by Drug
5.2.2 Canada Inhalation Anesthesia Market by Application
5.3 Mexico Inhalation Anesthesia Market
5.3.1 Mexico Inhalation Anesthesia Market by Drug
5.3.2 Mexico Inhalation Anesthesia Market by Application
5.4 Rest of North America Inhalation Anesthesia Market
5.4.1 Rest of North America Inhalation Anesthesia Market by Drug
5.4.2 Rest of North America Inhalation Anesthesia Market by Application

Chapter 6. Company Profiles
6.1 Novartis AG
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Product Launches and Product Expansions:
6.2 Piramal Enterprises Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Hikma Pharmaceuticals PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.4 Fresenius SE & Co. KGaA
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Baxter International, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals and Trials:
6.6 AbbVie, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 Halocarbon Products Corporation
6.7.1 Company Overview
6.8 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
6.8.1 Company Overview
6.9 Lunan Pharmaceutical Group Co., Ltd.
6.9.1 Company Overview
6.10. Troikaa Pharmaceuticals Limited
6.10.1 Company Overview